The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior […]
Insights
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray is joined by IDEA Pharma colleagues David Radwaner and
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is
2026 Global Pharmaceutical Innovation and Invention Index
The annual ranking of the world’s leading pharma companies by their ability to create new ideas and turn them into
Eli Lilly top 2026 Global Pharmaceutical Innovation & Invention Index
Eli Lilly First Ever Company to Top Both Rankings in the 2026 Pharmaceutical Innovation and Invention Index See the full results at https://www.ideapharma.com/pii/report/global/ LONDON, UK — May 19th 2026 — The 2026 Global Pharmaceutical Innovation
2026 Freshness Index
The Freshness Index shows the percentage of company sales generated by products launched in the last three and five years.
IDEA Pharma – Vyvanse Positioning Case Study
IDEA Pharma work with Biopharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy. The IDEA Pharma
Building the In Vivo Future: What Lilly’s Kelonia Bet Really Signals
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but
Adapting to the AI Era: Simulating Patient and Physician Perspectives at Scale
As recently profiled in the New York Times, the rise of AI chatbots in healthcare is fundamentally changing how patients form
Is AI at the helm of biopharma business development strategies?
Jacqueline Poot President – Strategic Consulting & Analytics BU IDEA Pharma As a moderator of this session at BIOEuropeSpring, my